聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 28 分钟 56 秒 前

Esaote Receives FDA Clearance for Its Compact MyLab Six Ultrasound System

周四, 09/04/2014 - 13:35
Configurable applications and compact design combine in new affordable shared service ultrasound INDIANAPOLIS--(Healthcare Sales & Marketing Network)--Esaote North America announced that its new MyLab Six ultrasound system has received 510(k) clearance ...
Devices, FDA
Esaote North America, MyLab Six, ultrasound

Stereotaxis Receives FDA Clearance of Vdrive(TM) With V-Loop(TM) System

周四, 09/04/2014 - 13:28
ST. LOUIS, Sept. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Stereotaxis, Inc. (STXS) announced today that it has received 510(k) clearance by the Food and Drug Administration (FDA) to market its Vdrive(TM) Robotic Navigation System with V-Loop(TM...
Devices, FDA
Stereotaxis, Vdrive, Robotic Navigation System

Johnson and Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid

周四, 09/04/2014 - 13:22
NEW BRUNSWICK, N.J., Sept. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson (JNJ) today announced it will fast-track the development of a promising new combination vaccine regimen against Ebola and broadly collaborate with its partne...
Biopharmaceuticals
Johnson & Johnson, Crucell, Janssen, Ebola, Filoviridae

BIND Therapeutics Appoints Two New Board Members

周三, 09/03/2014 - 15:44
Industry leaders, Eric K. Rowinsky, M.D. and Amy W. Schulman, join BIND’s Board of Directors CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--BIND Therapeutics, Inc. (BIND), a clinical-stage nanomedicine platform company developing targeted and...
Biopharmaceuticals, Oncology, Personnel
BIND Therapeutics, Accurins, Medicinal Nanoengineering

Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board

周三, 09/03/2014 - 15:42
EWING, N.J., Sept. 3, 2014 -- (Healthcare Sales & Marketing Network) -- Celator Pharmaceuticals, Inc. (CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the appointment of Michael R. Dougherty as C...
Biopharmaceuticals, Oncology, Personnel
Celator Pharmaceuticals

MRI Interventions Welcomes Pascal E.R. Girin to Board of Directors

周三, 09/03/2014 - 15:40
Newest Director Brings Additional Medical Device Management Experience, Executive Perspective to Board IRVINE, Calif., Sept. 3, 2014 -- (Healthcare Sales & Marketing Network) -- MRI Interventions, Inc. (MRIC) today announced that industry veteran Pascal...
Devices, Radiology, Surgery, Personnel
MRI Interventions, ClearPoint, intraoperative MRI

GE Healthcare Announces FDA Approval of SenoClaire, New Breast Imaging with 3D Tomosynthesis Solution

周三, 09/03/2014 - 15:19
WAUWATOSA, Wis.--(Healthcare Sales & Marketing Network)--GE Healthcare (GE) today announced the FDA approval of SenoClaire*, GE’s new breast tomosynthesis solution designed with a three-dimensional imaging technology. In collaboration with Massachusetts Ge...
Devices, Radiology, Oncology, FDA
GE Healthcare, SenoClaire, breast tomosynthesis, imaging

ProNAi Therapeutics, Inc. Names New President and Chief Executive Officer

周三, 09/03/2014 - 15:16
PLYMOUTH, Mich.--(Healthcare Sales & Marketing Network)--ProNAi Therapeutics, Inc., a developer of novel nucleic acid therapeutics, announces the appointment Nick Glover, Ph.D. as President and Chief Executive Officer. The company’s previous CEO, Mina Sooc...
Biopharmaceuticals, Personnel
ProNAi Therapeutics

SinuSys Corp. Names Robert Hoxie as Chief Commercial Officer

周三, 09/03/2014 - 15:14
PALO ALTO, Calif.--(Healthcare Sales & Marketing Network)--SinuSys Corp., an innovative sinus health company, today announced that Robert Hoxie has joined the company as chief commercial officer, effective September 1. Mr. Hoxie will provide strategic sale...
Devices, Personnel
SinuSys, Vent-Os, Sinus Dilation System

Intensity Therapeutics, Inc. Appoints Ian B. Walters M.D., MBA as Vice President and Chief Medical Officer

周三, 09/03/2014 - 15:12
WESTPORT, Conn.--(Healthcare Sales & Marketing Network)--Intensity Therapeutics, Inc., a privately-held specialty pharmaceutical company developing novel products to treat solid tumor cancers, announced today that Ian B. Walters M.D., MBA, has been appoint...
Biopharmaceuticals, Oncology, Personnel
Intensity Therapeutics, in situ chemovaccination

Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer

周三, 09/03/2014 - 15:10
Industry Veteran Brings More than 35 Years of Expertise in CNS Drug Discovery and Development CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Voyager Therapeutics, a gene therapy company developing life-changing treatments for fatal and debili...
Biopharmaceuticals, Neurology, Personnel
Voyager Therapeutics

Eisai Sells U.S. Rights to Zonegran(R) (zonisamide) Capsules to Concordia Pharmaceuticals Inc.

周三, 09/03/2014 - 15:08
WOODCLIFF LAKE, N.J., Sept. 3, 2014 -- (Healthcare Sales & Marketing Network) -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announced it has entered into an agreement with Concordia Pharmaceuticals Inc. ("Concordia"...
Biopharmaceuticals, Acquisitions
Eisai, Concordia Pharmaceuticals, Zonegran, zonisamide

Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer

周三, 09/03/2014 - 14:55
New US Subsidiary to be located in the Philadelphia Area VIENNA, September 3, 2014 -- (Healthcare Sales & Marketing Network) --Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the tre...
Biopharmaceuticals, Personnel
Nabriva Therapeutics, antibiotic, pleuromutilins

Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG

周二, 09/02/2014 - 13:19
MARLBOROUGH, Mass., Sept. 2, 2014 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer AG. The acquisition enhances the ability of Bo...
Devices, Interventional, Mergers & Acquisitions
Boston Scientific, Bayer AG, AngioJet, Fetch 2, JetStream

Integra LifeSciences Announces Changes Within Its Orthopedics and Tissue Technologies Business

周二, 09/02/2014 - 13:15
PLAINSBORO, N.J., Sept. 2, 2014 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) today announced that it has made changes to the leadership of its Orthopedics and Tissue Technologies business. The new organizati...
Devices, Orthopaedic, Personnel
Integra LifeSciences

Clearside Biomedical, Inc. Completes $16 Million Series B Financing

周二, 09/02/2014 - 12:56
ALPHARETTA, Ga.--(Healthcare Sales & Marketing Network)--Clearside Biomedical, Inc., today announced the closing of a $16 million Series B financing. The financing included new investor RusnanoMedInvest (RMI) and existing investors Hatteras Venture Partner...
Biopharmaceuticals, Ophthalmology, Venture Capital
Clearside Biomedica

Sorin Group Announces First World Implant of CROWN PRT(TM) Heart Valve

周二, 09/02/2014 - 12:46
New stented aortic bioprosthesis with outstanding ease of use and performance successfully implanted in Austria MILAN--(Healthcare Sales & Marketing Network)--Sorin Group (SRN.MI), (Reuters Code: SORN.MI), a global medical company and a leader in the tr...
Devices, Cardiology
Sorin Group, CROWN PRT, aortic bioprosthesis, heart valve

Elekta’s Versa HD Radiation Therapy System Now Available for Treatment of Cancer Patients in Japan

周二, 09/02/2014 - 12:35
Linear accelerator receives clearance from country’s Ministry of Health, Labor and Welfare STOCKHOLM--(Healthcare Sales & Marketing Network)--Cancer care providers in Japan have the opportunity to strengthen their cancer treatment capacity with the rece...
Devices, Oncology, Regulatory
Elekta, Versa HD, linear accelerator, radiotherapy

GE Healthcare Announces European Union Approval of VIZAMYL(TM) (Flutemetamol (18F) Solution for Injection) for PET Imaging of Beta Amyloid Plaque in Suspected Alzheimer’s Disease

周一, 09/01/2014 - 18:43
PET Imaging Agent Receives Marketing Authorisation from the European Commission CHALFONT ST. GILES, England--(Healthcare Sales & Marketing Network)--GE Healthcare announced today that VIZAMYL™ (flutemetamol (18F) solution for injection) has received mar...
Biopharmaceuticals, Devices, Radiology, Oncology, Regulatory
GE Healthcare, VIZAMYL, Flutemetamol, Positron Emission Tomography

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong